Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT

W.P. Maksymowych; R Lambert; E  Krishnan; B Zhu; R Bolce; Mikkel Østergaard

Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT

W.P. Maksymowych, R Lambert, E Krishnan, B Zhu, R Bolce, Mikkel Østergaard

Department for Rheumatology and Spine Diseases

Original language	English
Publication date	2023
Publication status	Published - 2023
Event	ACR Convergence 2023 - San Diego, United States Duration: 10 Nov 2023 → 15 Nov 2023

Conference

Conference	ACR Convergence 2023
Country/Territory	United States
City	San Diego
Period	10/11/2023 → 15/11/2023

Cite this

Maksymowych, W. P., Lambert, R., Krishnan, E., Zhu, B., Bolce, R., & Østergaard, M. (2023). Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT. Arthritis & Rheumatology 75 (suppl 9), abstract no 2549. Abstract from ACR Convergence 2023, San Diego, United States.

Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT. / Maksymowych, W.P.; Lambert, R; Krishnan, E et al.
2023. Arthritis & Rheumatology 75 (suppl 9), abstract no 2549 Abstract from ACR Convergence 2023, San Diego, United States.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Maksymowych, WP, Lambert, R, Krishnan, E, Zhu, B, Bolce, R & Østergaard, M 2023, 'Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT', ACR Convergence 2023, San Diego, United States, 10/11/2023 - 15/11/2023 pp. Arthritis & Rheumatology 75 (suppl 9), abstract no 2549.

@conference{5cfcbe8791b044c9bbc188602ec82694,

title = "Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT",

author = "W.P. Maksymowych and R Lambert and E Krishnan and B Zhu and R Bolce and Mikkel {\O}stergaard",

note = "COPECARE; ACR Convergence 2023 ; Conference date: 10-11-2023 Through 15-11-2023",

year = "2023",

language = "English",

pages = "Arthritis \& Rheumatology 75 (suppl 9), abstract no 2549",

}

TY - ABST

T1 - Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT

AU - Maksymowych, W.P.

AU - Lambert, R

AU - Krishnan, E

AU - Zhu, B

AU - Bolce, R

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2023

Y1 - 2023

M3 - Conference abstract for conference

SP - Arthritis & Rheumatology 75 (suppl 9), abstract no 2549

T2 - ACR Convergence 2023

Y2 - 10 November 2023 through 15 November 2023

ER -